EPOPROSTENOL

EPOPROSTENOL was reported 13103 times

EPOPROSTENOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CATHETER MANAGEMENT 524 0.5829
1 CATHETER SITE PRURITUS 416 0.4738
2 BLOOD CULTURE NEGATIVE 34 0.4722
3 CATHETER SITE DERMATITIS 15 0.4167
4 CATHETER SITE RASH 182 0.4027
5 CATHETER SITE SCAB 43 0.4019
6 GASTRITIS HYPERTROPHIC 16 0.3902
7 CATHETER CULTURE POSITIVE 27 0.3803
8 CATHETER SITE VESICLES 73 0.3744
9 CATHETER SITE IRRITATION 112 0.3363
10 CATHETER SITE DRYNESS 12 0.3077
11 CATHETER SITE DISCHARGE 302 0.2687
12 CATHETER SITE ERYTHEMA 564 0.2633
13 CATHETER SITE URTICARIA 8 0.2424
14 TRANSPLANT EVALUATION 122 0.2402
15 HEART AND LUNG TRANSPLANT 30 0.2326
16 CATHETER SITE DISCOLOURATION 26 0.2131
17 FIRST BITE SYNDROME 8 0.2105
18 CATHETER SITE INFLAMMATION 114 0.2025
19 CATHETER SITE HYPERSENSITIVITY 8 0.2000
20 CATHETER SITE WARMTH 32 0.1963
21 CHRONIC RIGHT VENTRICULAR FAILURE 7 0.1892
22 PULMONARY CAPILLARY HAEMANGIOMATOSIS 9 0.1636
23 PARACENTESIS 96 0.1561
24 DEVICE ALARM ISSUE 282 0.1552
25 CATHETER SITE SWELLING 145 0.1549
26 CATHETER SITE EROSION 13 0.1429
27 CATHETER PLACEMENT 255 0.1374
28 CATHETER SITE PAIN 342 0.1317
29 CATHETER REMOVAL 45 0.1261
30 DIURETIC THERAPY 9 0.1250
31 CARDIAC FAILURE HIGH OUTPUT 29 0.1203
32 PORTOPULMONARY HYPERTENSION 10 0.1124
33 MEDICAL DEVICE CHANGE 58 0.1088
34 CATHETER SITE CELLULITIS 31 0.1058
35 PULMONARY VASCULAR RESISTANCE ABNORMALITY 9 0.1047
36 CATHETER SITE HAEMORRHAGE 253 0.1010
37 ACUTE RIGHT VENTRICULAR FAILURE 15 0.0882
38 CATHETER SITE INFECTION 329 0.0869
39 ABDOMINAL CAVITY DRAINAGE 35 0.0829
40 CATHETER SITE RELATED REACTION 62 0.0827
41 PULMONARY VENO-OCCLUSIVE DISEASE 57 0.0814
42 RIGHT VENTRICULAR FAILURE 564 0.0804
43 DEVICE DAMAGE 61 0.0765
44 PULMONARY ARTERIAL HYPERTENSION 1105 0.0762
45 CATHETER SITE OEDEMA 8 0.0734
46 CATHETER SITE NODULE 14 0.0733
47 BIOPSY LYMPH GLAND 7 0.0714
48 LUNG TRANSPLANT 252 0.0711
49 CATHETER SITE INDURATION 13 0.0674
50 PAIN IN JAW 1859 0.0656
51 CENTRAL VENOUS CATHETERISATION 194 0.0643
52 WALKING DISTANCE TEST ABNORMAL 25 0.0639
53 PULMONARY ARTERIAL PRESSURE INCREASED 102 0.0626
54 PULMONARY ARTERIAL PRESSURE ABNORMAL 18 0.0625
55 VENTILATION PERFUSION MISMATCH 17 0.0605
56 CATHETER SITE MASS 9 0.0592
57 ENDARTERECTOMY 13 0.0580
58 CATHETER SITE EXTRAVASATION 23 0.0576
59 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 10 0.0575
60 CATHETER SITE THROMBOSIS 15 0.0547
61 VASCULAR DEVICE OCCLUSION 18 0.0531
62 CARDIAC OUTPUT INCREASED 9 0.0526
63 CATHETERISATION CARDIAC ABNORMAL 14 0.0519
64 CATHETER SITE ABSCESS 9 0.0517
65 CENTRAL VENOUS CATHETER REMOVAL 22 0.0469
66 ATRIAL SEPTAL DEFECT REPAIR 8 0.0465
67 OXYGEN CONSUMPTION INCREASED 108 0.0452
68 DEVICE INFUSION ISSUE 106 0.0427
69 CHEST TUBE INSERTION 8 0.0426
70 VASCULAR DEVICE INFECTION 192 0.0423
71 DEVICE RELATED SEPSIS 85 0.0422
72 DEVICE RELATED INFECTION 647 0.0420
73 ASPIRATION PLEURAL CAVITY 32 0.0416
74 THROMBOSIS IN DEVICE 134 0.0408
75 COR PULMONALE CHRONIC 7 0.0372
76 BIOPSY LIVER 15 0.0365
77 RIGHT VENTRICULAR DILATATION 21 0.0363
78 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 11 0.0347
79 FLUID OVERLOAD 498 0.0342
80 DEVICE CONNECTION ISSUE 71 0.0336
81 CREST SYNDROME 8 0.0336
82 THERAPEUTIC EMBOLISATION 10 0.0321
83 DYSPNOEA AT REST 91 0.0314
84 STAPHYLOCOCCUS TEST POSITIVE 66 0.0313
85 MINERAL SUPPLEMENTATION 14 0.0312
86 BLOOD CULTURE POSITIVE 93 0.0310
87 CATHETER SITE BRUISE 10 0.0302
88 DIZZINESS EXERTIONAL 22 0.0289
89 RIGHT VENTRICULAR DYSFUNCTION 31 0.0281
90 BIOPSY BONE MARROW 13 0.0278
91 PULMONARY HYPERTENSION 575 0.0276
92 DEVICE OCCLUSION 365 0.0259
93 DYSPNOEA EXERTIONAL 969 0.0257
94 LYMPHOCYTIC HYPOPHYSITIS 7 0.0254
95 LIFE SUPPORT 14 0.0250
96 DEVICE RELATED THROMBOSIS 24 0.0243
97 CATHETERISATION CARDIAC 107 0.0241
98 OXYGEN THERAPY 38 0.0231
99 SUTURE RELATED COMPLICATION 16 0.0226
100 JUGULAR VEIN DISTENSION 12 0.0212
101 SCLERODERMA 75 0.0206
102 CARDIAC ABLATION 36 0.0201
103 HAEMOPERITONEUM 16 0.0200
104 RIGHT ATRIAL DILATATION 10 0.0197
105 THERAPY CHANGE 193 0.0196
106 EMERGENCY CARE 56 0.0185
107 RESPIRATORY TRACT HAEMORRHAGE 11 0.0184
108 TRANSFUSION 193 0.0184
109 CHRONIC RESPIRATORY FAILURE 22 0.0182
110 FLUID RETENTION 926 0.0182
111 PRODUCT DEPOSIT 28 0.0180
112 HEPATIC CONGESTION 17 0.0180
113 CONGESTIVE HEPATOPATHY 8 0.0179
114 CULTURE POSITIVE 14 0.0167
115 TRANSPLANT 39 0.0164
116 INFUSION SITE WARMTH 20 0.0163
117 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 9 0.0160
118 INFUSION SITE RASH 22 0.0160
119 PORTAL HYPERTENSIVE GASTROPATHY 9 0.0160
120 SUTURE RUPTURE 11 0.0159
121 COR PULMONALE 15 0.0157
122 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 22 0.0157
123 FEMALE STERILISATION 8 0.0156
124 TELANGIECTASIA 15 0.0155
125 INTRA-ABDOMINAL FLUID COLLECTION 27 0.0151
126 RETINOPATHY OF PREMATURITY 8 0.0144
127 PACKED RED BLOOD CELL TRANSFUSION 19 0.0144
128 ARTERIOVENOUS MALFORMATION 13 0.0143
129 ECHOCARDIOGRAM ABNORMAL 20 0.0143
130 BRAIN NATRIURETIC PEPTIDE INCREASED 44 0.0143
131 COMPLICATION ASSOCIATED WITH DEVICE 207 0.0142
132 DERMATITIS CONTACT 160 0.0140
133 DELIVERY 9 0.0137
134 LIVER TRANSPLANT 46 0.0126
135 TRACHEOSTOMY 18 0.0126
136 NOCTURNAL DYSPNOEA 16 0.0125
137 INFUSION SITE DISCHARGE 22 0.0125
138 POLYPECTOMY 10 0.0125
139 CARDIORENAL SYNDROME 7 0.0122
140 PSEUDOMONAS TEST POSITIVE 10 0.0122
141 CARDIOVERSION 17 0.0122
142 INFUSION SITE IRRITATION 15 0.0117
143 MECHANICAL VENTILATION 22 0.0116
144 FLUSHING 1174 0.0115
145 CARDIAC OUTPUT DECREASED 10 0.0113
146 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 12 0.0113
147 HEART TRANSPLANT 10 0.0110
148 ASCITES 325 0.0110
149 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 7 0.0109
150 ENDOTRACHEAL INTUBATION 30 0.0107
151 PRODUCT ADMINISTRATION INTERRUPTED 82 0.0104
152 INFUSION SITE INFECTION 24 0.0103
153 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 9 0.0103
154 HYPOXIA 359 0.0102
155 INFUSION SITE PRURITUS 32 0.0101
156 PLATELET TRANSFUSION 13 0.0101
157 THYROIDECTOMY 17 0.0098
158 INFUSION SITE ERYTHEMA 82 0.0097
159 THYROTOXIC CRISIS 11 0.0097
160 SYSTOLIC DYSFUNCTION 10 0.0095
161 CARDIAC INFECTION 7 0.0093
162 DISEASE COMPLICATION 42 0.0092
163 ORTHOPNOEA 29 0.0091
164 ARTERIAL RUPTURE 7 0.0091
165 APPLICATION SITE HYPERSENSITIVITY 11 0.0091
166 OXYGEN SATURATION DECREASED 493 0.0088
167 BRONCHOPULMONARY DYSPLASIA 7 0.0087
168 CONCOMITANT DISEASE PROGRESSION 17 0.0087
169 INFUSION SITE DISCOMFORT 9 0.0087
170 OEDEMA 465 0.0086
171 VASODILATATION 21 0.0083
172 HYPERVOLAEMIA 41 0.0083
173 DYSENTERY 15 0.0081
174 LOCALISED OEDEMA 37 0.0080
175 DEVICE LEAKAGE 345 0.0079
176 OXYGEN SATURATION ABNORMAL 22 0.0077
177 SKIN SENSITISATION 8 0.0077
178 MIDDLE EAR EFFUSION 17 0.0077
179 DEVICE DISLOCATION 334 0.0077
180 ATRIAL TACHYCARDIA 16 0.0076
181 PULMONARY ALVEOLAR HAEMORRHAGE 42 0.0075
182 PERICARDIAL EFFUSION 172 0.0074
183 MEDICAL DEVICE COMPLICATION 55 0.0074
184 EAR CONGESTION 20 0.0074
185 ISCHAEMIC HEPATITIS 10 0.0073
186 ACUTE RESPIRATORY FAILURE 136 0.0071
187 INFUSION SITE PAIN 91 0.0071
188 CREPITATIONS 21 0.0070
189 INTENSIVE CARE 10 0.0070
190 ATRIAL FLUTTER 56 0.0070
191 EXERCISE TOLERANCE DECREASED 40 0.0069
192 PANCREATIC CYST 13 0.0068
193 INFUSION SITE HAEMORRHAGE 22 0.0067
194 CONCOMITANT DISEASE AGGRAVATED 41 0.0066
195 UPPER RESPIRATORY TRACT CONGESTION 19 0.0066
196 HAEMOPTYSIS 183 0.0066
197 DISCHARGE 9 0.0065
198 COLONOSCOPY 14 0.0063
199 HYPOPITUITARISM 11 0.0063
200 STAPHYLOCOCCAL BACTERAEMIA 27 0.0062
201 HEART VALVE REPLACEMENT 9 0.0061
202 ANGIOPLASTY 9 0.0060
203 PULSELESS ELECTRICAL ACTIVITY 25 0.0060
204 BLOOD PRESSURE SYSTOLIC DECREASED 27 0.0059
205 INFUSION SITE SWELLING 37 0.0059
206 NASAL DISCHARGE DISCOLOURATION 8 0.0058
207 HERNIA REPAIR 15 0.0058
208 BACTERAEMIA 68 0.0057
209 CONNECTIVE TISSUE DISORDER 8 0.0056
210 PULMONARY OEDEMA 241 0.0054
211 CARDIOGENIC SHOCK 77 0.0054
212 CLOSTRIDIUM DIFFICILE INFECTION 117 0.0054
213 LOWER RESPIRATORY TRACT CONGESTION 9 0.0053
214 STAPHYLOCOCCAL SEPSIS 26 0.0053
215 SEASONAL ALLERGY 74 0.0052
216 PRESYNCOPE 126 0.0052
217 BLOOD POTASSIUM DECREASED 154 0.0051
218 MULTIPLE ALLERGIES 40 0.0051
219 EAR DISCOMFORT 52 0.0051
220 HYPERTHYROIDISM 72 0.0050
221 CARDIAC DISCOMFORT 10 0.0050
222 PALPITATIONS 577 0.0049
223 DYSPNOEA 2785 0.0049
224 GOITRE 20 0.0049
225 PULMONARY HAEMORRHAGE 38 0.0049
226 DEVICE PHYSICAL PROPERTY ISSUE 37 0.0048
227 RALES 28 0.0048
228 CARDIAC FAILURE ACUTE 32 0.0048
229 SINUS PAIN 11 0.0047
230 CARDIAC FAILURE CHRONIC 20 0.0047
231 PURULENT DISCHARGE 20 0.0047
232 LEFT VENTRICULAR FAILURE 16 0.0046
233 CARDIAC FLUTTER 30 0.0046
234 DEVICE BREAKAGE 185 0.0046
235 OEDEMA PERIPHERAL 552 0.0045
236 NASAL CONGESTION 266 0.0045
237 GASTROSTOMY 7 0.0045
238 PARANASAL SINUS DISCOMFORT 17 0.0045
239 DIALYSIS 62 0.0044
240 RHINOVIRUS INFECTION 17 0.0044
241 INFUSION SITE REACTION 13 0.0043
242 BODY TEMPERATURE ABNORMAL 8 0.0043
243 DIZZINESS POSTURAL 42 0.0043
244 HOSPITALISATION 661 0.0043
245 CARDIAC FAILURE 344 0.0043
246 SUPRAVENTRICULAR TACHYCARDIA 41 0.0043
247 TRISMUS 22 0.0043
248 RESPIRATORY FAILURE 308 0.0042
249 MEDICAL PROCEDURE 7 0.0042
250 CHOLECYSTECTOMY 48 0.0042
251 OCULAR HYPERTENSION 8 0.0041
252 CARDIOPULMONARY FAILURE 16 0.0041
253 PREMATURE DELIVERY 65 0.0041
254 HYPOTENSION 815 0.0041
255 HOSPICE CARE 40 0.0040
256 CARDIOMEGALY 49 0.0040
257 GASTROINTESTINAL OEDEMA 7 0.0040
258 DRUG DELIVERY SYSTEM MALFUNCTION 20 0.0039
259 CHEST PAIN 721 0.0039
260 TERMINAL STATE 26 0.0039
261 DRUG TITRATION ERROR 10 0.0039
262 FACIAL PAIN 34 0.0038
263 HAEMODYNAMIC INSTABILITY 29 0.0038
264 PULMONARY PAIN 11 0.0038
265 PNEUMONIA VIRAL 12 0.0038
266 BRAIN HERNIATION 11 0.0037
267 HEADACHE 2302 0.0037
268 INJECTION SITE INFECTION 12 0.0036
269 RHINALGIA 10 0.0036
270 STAPHYLOCOCCAL INFECTION 120 0.0036
271 UNEVALUABLE EVENT 275 0.0036
272 CLOSTRIDIUM TEST POSITIVE 8 0.0036
273 SYNCOPE 363 0.0036
274 PNEUMONIA CYTOMEGALOVIRAL 7 0.0036
275 PORTAL HYPERTENSION 11 0.0036
276 SKIN INFECTION 40 0.0036
277 SINUS CONGESTION 48 0.0035
278 FOOD POISONING 19 0.0035
279 EPISTAXIS 265 0.0035
280 CARDIAC PACEMAKER INSERTION 21 0.0035
281 CAESAREAN SECTION 41 0.0035
282 SINUS DISORDER 69 0.0035
283 NON-CARDIAC CHEST PAIN 11 0.0035
284 STENT PLACEMENT 28 0.0035
285 APPLICATION SITE PRURITUS 78 0.0034
286 ABDOMINAL DISTENSION 358 0.0034
287 GOUT 61 0.0034
288 LOW BIRTH WEIGHT BABY 27 0.0034
289 PRODUCTIVE COUGH 162 0.0034
290 GENERALISED OEDEMA 42 0.0034
291 DIARRHOEA 2178 0.0034
292 BLOOD IRON DECREASED 40 0.0034
293 PNEUMOTHORAX 53 0.0033
294 AMMONIA INCREASED 17 0.0033
295 DILATATION VENTRICULAR 7 0.0033
296 HYPERCAPNIA 10 0.0033
297 ENDOCARDITIS 17 0.0033
298 COVID-19 PNEUMONIA 39 0.0033
299 DEVICE KINK 12 0.0033
300 MENTAL STATUS CHANGES 91 0.0033
301 THERAPY NON-RESPONDER 144 0.0032
302 NASAL DRYNESS 20 0.0032
303 INVESTIGATION 10 0.0032
304 SKIN ABRASION 15 0.0032
305 CHEMOTHERAPY 12 0.0032
306 PALLOR 86 0.0032
307 VIRAL UPPER RESPIRATORY TRACT INFECTION 15 0.0032
308 RESPIRATORY DISTRESS 87 0.0031
309 PARANASAL SINUS HYPERSECRETION 12 0.0031
310 GASTRIC INFECTION 12 0.0031
311 GASTRIC POLYPS 7 0.0031
312 PLEURAL EFFUSION 187 0.0031
313 HAEMOGLOBIN INCREASED 14 0.0031
314 APPLICATION SITE IRRITATION 38 0.0031
315 RESPIRATORY ACIDOSIS 12 0.0030
316 LUNG OPACITY 8 0.0030
317 BLOOD MAGNESIUM DECREASED 26 0.0030
318 DEVICE MALFUNCTION 209 0.0030
319 SKIN DISCOMFORT 8 0.0030
320 CELLULITIS 149 0.0030
321 RETCHING 63 0.0030
322 CARDIAC TAMPONADE 14 0.0029
323 POLYURIA 24 0.0029
324 HEART RATE INCREASED 289 0.0029
325 DIASTOLIC DYSFUNCTION 9 0.0029
326 PAIN IN EXTREMITY 857 0.0029
327 PAINFUL RESPIRATION 7 0.0029
328 PULMONARY CONGESTION 38 0.0029
329 HYPOPNOEA 10 0.0029
330 RESPIRATORY SYNCYTIAL VIRUS INFECTION 25 0.0029
331 PREMATURE BABY 86 0.0029
332 DISEASE PROGRESSION 338 0.0029
333 REHABILITATION THERAPY 11 0.0028
334 BREATH SOUNDS ABNORMAL 14 0.0028
335 PREMATURE LABOUR 16 0.0028
336 INCORRECT DRUG ADMINISTRATION RATE 12 0.0028
337 HEART VALVE INCOMPETENCE 8 0.0028
338 CARDIAC OPERATION 24 0.0028
339 CHAPPED LIPS 12 0.0028
340 HAEMOTHORAX 8 0.0028
341 MULTIPLE ORGAN DYSFUNCTION SYNDROME 78 0.0028
342 PNEUMONIA 886 0.0027
343 MUSCULOSKELETAL PAIN 143 0.0027
344 GALLBLADDER OPERATION 11 0.0027
345 SHOCK HAEMORRHAGIC 22 0.0027
346 CATARACT OPERATION 16 0.0027
347 UPPER RESPIRATORY TRACT INFECTION 124 0.0027
348 SEPSIS 299 0.0027
349 THYROIDITIS 8 0.0027
350 MUSCLE STRAIN 23 0.0027
351 NASAL DISCOMFORT 21 0.0026
352 AUTOIMMUNE THYROIDITIS 10 0.0026
353 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
354 CONDITION AGGRAVATED 801 0.0026
355 BLOOD POTASSIUM ABNORMAL 7 0.0026
356 INTERNAL HAEMORRHAGE 30 0.0026
357 CHEST X-RAY ABNORMAL 8 0.0026
358 HEPATIC CIRRHOSIS 49 0.0026
359 HEAD DISCOMFORT 46 0.0026
360 OLIGURIA 16 0.0026
361 NORMAL NEWBORN 14 0.0026
362 SPLENOMEGALY 30 0.0026
363 BLOOD BLISTER 8 0.0026
364 CYANOSIS 40 0.0025
365 SARCOIDOSIS 12 0.0025
366 VIRAL INFECTION 84 0.0025
367 CHOLECYSTITIS INFECTIVE 7 0.0025
368 SWELLING 235 0.0025
369 ABNORMAL LOSS OF WEIGHT 17 0.0025
370 DRUG TOLERANCE DECREASED 7 0.0025
371 GASTROENTERITIS VIRAL 45 0.0025
372 NAUSEA 1970 0.0025
373 CHEST DISCOMFORT 254 0.0025
374 WEIGHT DECREASED 689 0.0025
375 RESPIRATION ABNORMAL 17 0.0025
376 GALLBLADDER DISORDER 44 0.0025
377 PERIPHERAL SWELLING 378 0.0025
378 PERIPHERAL ISCHAEMIA 10 0.0024
379 IRON DEFICIENCY 11 0.0024
380 LUNG DISORDER 119 0.0024
381 LOCALISED INFECTION 58 0.0024
382 WEIGHT FLUCTUATION 25 0.0024
383 SINUS HEADACHE 14 0.0024
384 NASOPHARYNGITIS 432 0.0023
385 HEPATOMEGALY 23 0.0023
386 FAECES SOFT 17 0.0023
387 HEART RATE ABNORMAL 13 0.0023
388 DECREASED APPETITE 539 0.0023
389 BLOOD COUNT ABNORMAL 35 0.0023
390 MICTURITION DISORDER 8 0.0023
391 VENOUS THROMBOSIS 9 0.0023
392 FIBROSIS 7 0.0023
393 SKIN IRRITATION 104 0.0023
394 EAR INFECTION 60 0.0023
395 GASTRIC DISORDER 77 0.0022
396 SECRETION DISCHARGE 28 0.0022
397 VOMITING 1051 0.0022
398 PANCREATIC DISORDER 11 0.0022
399 HEPARIN-INDUCED THROMBOCYTOPENIA 11 0.0022
400 HYPOVOLAEMIA 13 0.0022
401 NO THERAPEUTIC RESPONSE 27 0.0022
402 SPUTUM DISCOLOURED 21 0.0022
403 GASTROINTESTINAL HAEMORRHAGE 184 0.0022
404 APPLICATION SITE RASH 30 0.0022
405 SLUGGISHNESS 22 0.0022
406 LIVE BIRTH 18 0.0021
407 CHILLS 251 0.0021
408 OTITIS MEDIA 7 0.0021
409 MYALGIA 360 0.0021
410 RESPIRATORY TRACT INFECTION 55 0.0021
411 FACE INJURY 8 0.0021
412 MALABSORPTION 11 0.0021
413 BLOOD PRESSURE DECREASED 139 0.0021
414 COUGH 582 0.0021
415 ELECTROLYTE IMBALANCE 24 0.0021
416 SHOCK 47 0.0020
417 MALAISE 895 0.0020
418 HEPATIC FIBROSIS 7 0.0020
419 RENAL DISORDER 95 0.0020
420 DEVICE ISSUE 182 0.0020
421 PATENT DUCTUS ARTERIOSUS 8 0.0020
422 RESPIRATORY TRACT CONGESTION 32 0.0020
423 APPLICATION SITE VESICLES 13 0.0020
424 SEPTIC SHOCK 87 0.0020
425 HEAD INJURY 63 0.0020
426 NEONATAL RESPIRATORY DISTRESS SYNDROME 7 0.0020
427 RASH MACULAR 69 0.0020
428 APPENDICECTOMY 7 0.0020
429 PROCEDURAL COMPLICATION 15 0.0020
430 LUNG INFECTION 30 0.0019
431 ACUTE RESPIRATORY DISTRESS SYNDROME 34 0.0019
432 SINUSITIS 197 0.0019
433 HAEMOGLOBIN DECREASED 197 0.0019
434 MUSCULOSKELETAL DISCOMFORT 33 0.0019
435 RESPIRATORY RATE INCREASED 17 0.0019
436 LACERATION 18 0.0019
437 GASTRIC HAEMORRHAGE 22 0.0019
438 FEELING COLD 53 0.0019
439 SENSITIVE SKIN 14 0.0019
440 DEHYDRATION 253 0.0019
441 NEURALGIA 46 0.0019
442 TRICUSPID VALVE INCOMPETENCE 15 0.0019
443 EXPOSURE DURING PREGNANCY 117 0.0019
444 CARDIAC DYSFUNCTION 7 0.0019
445 MALNUTRITION 21 0.0019
446 LARGE INTESTINE POLYP 13 0.0019
447 CARDIAC FAILURE CONGESTIVE 150 0.0019
448 ABDOMINAL DISCOMFORT 311 0.0019
449 TOOTH EXTRACTION 23 0.0018
450 PHARYNGITIS STREPTOCOCCAL 20 0.0018
451 INFLUENZA 206 0.0018
452 HAEMORRHOIDAL HAEMORRHAGE 9 0.0018
453 DECUBITUS ULCER 15 0.0018
454 RASH ERYTHEMATOUS 88 0.0018
455 PULMONARY THROMBOSIS 20 0.0018
456 ACIDOSIS 14 0.0018
457 ATRIAL FIBRILLATION 178 0.0018
458 BACTERIAL INFECTION 34 0.0018
459 LUNG INFILTRATION 16 0.0018
460 BLOOD PRESSURE ABNORMAL 36 0.0018
461 SMALL INTESTINAL OBSTRUCTION 22 0.0018
462 ACUTE PULMONARY OEDEMA 10 0.0018
463 CARDIAC ARREST 147 0.0018
464 TACHYCARDIA 158 0.0018
465 DYSPEPSIA 174 0.0018
466 LIMB INJURY 48 0.0018
467 DECREASED ACTIVITY 19 0.0018
468 ATELECTASIS 17 0.0018
469 COLD SWEAT 31 0.0018
470 GENERALISED ERYTHEMA 10 0.0018
471 INTERNATIONAL NORMALISED RATIO INCREASED 50 0.0018
472 SCAB 20 0.0018
473 SKIN LACERATION 19 0.0017
474 WEIGHT INCREASED 390 0.0017
475 INFECTION 252 0.0017
476 ORGAN FAILURE 7 0.0017
477 ABDOMINAL PAIN 404 0.0017
478 LIVER DISORDER 77 0.0017
479 FAILURE TO THRIVE 9 0.0017
480 RENAL FUNCTION TEST ABNORMAL 8 0.0017
481 POST PROCEDURAL COMPLICATION 33 0.0017
482 LOWER LIMB FRACTURE 33 0.0017
483 URINE OUTPUT DECREASED 15 0.0017
484 BRONCHITIS 127 0.0017
485 TOOTHACHE 31 0.0017
486 SENSITIVITY TO WEATHER CHANGE 9 0.0017
487 TROPONIN INCREASED 13 0.0017
488 CHOLELITHIASIS 56 0.0017
489 FEELING OF BODY TEMPERATURE CHANGE 10 0.0017
490 ESCHERICHIA INFECTION 14 0.0017
491 ABDOMINAL PAIN UPPER 348 0.0017
492 SUBDURAL HAEMATOMA 24 0.0017
493 LOSS OF CONSCIOUSNESS 214 0.0017
494 DIZZINESS 832 0.0017
495 ANAL INCONTINENCE 15 0.0017
496 NECK PAIN 93 0.0017
497 HIP SURGERY 9 0.0017
498 RASH PRURITIC 90 0.0017
499 RASH GENERALISED 43 0.0017
500 JAW DISORDER 9 0.0016
501 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
502 TENDERNESS 17 0.0016
503 COLITIS ISCHAEMIC 11 0.0016
504 THROMBOCYTOPENIA 181 0.0016
505 HAEMATEMESIS 41 0.0016
506 HYSTERECTOMY 14 0.0016
507 PYREXIA 559 0.0016
508 INFUSION SITE EXTRAVASATION 10 0.0016
509 SYSTEMIC LUPUS ERYTHEMATOSUS 57 0.0016
510 ANAEMIA 303 0.0016
511 ERYTHEMA 326 0.0016
512 FEELING HOT 97 0.0016
513 RHINORRHOEA 102 0.0016
514 DEVICE FAILURE 24 0.0016
515 TOOTH ABSCESS 16 0.0016
516 BACK PAIN 365 0.0016
517 HAEMODIALYSIS 13 0.0015
518 SKIN WARM 9 0.0015
519 DEATH 1329 0.0015
520 BLOOD POTASSIUM INCREASED 25 0.0015
521 SWELLING FACE 100 0.0015
522 PRODUCT ADMINISTRATION ERROR 31 0.0015
523 EAR DISORDER 7 0.0015
524 CIRCULATORY COLLAPSE 26 0.0015
525 APPLICATION SITE ERYTHEMA 40 0.0015
526 PNEUMONIA BACTERIAL 14 0.0015
527 BLOOD BILIRUBIN INCREASED 41 0.0015
528 TOOTH INFECTION 20 0.0015
529 IRON DEFICIENCY ANAEMIA 14 0.0015
530 ASTHENIA 569 0.0015
531 HAEMATOCRIT DECREASED 30 0.0015
532 CHOLECYSTITIS 18 0.0015
533 HEART RATE IRREGULAR 34 0.0015
534 PLATELET COUNT DECREASED 160 0.0015
535 HEPATIC ENCEPHALOPATHY 14 0.0015
536 THYROID DISORDER 23 0.0015
537 RENAL FAILURE 198 0.0015
538 KIDNEY INFECTION 29 0.0015
539 CARDIAC DISORDER 137 0.0015
540 POST PROCEDURAL HAEMORRHAGE 17 0.0015
541 LIMB OPERATION 7 0.0015
542 UPPER-AIRWAY COUGH SYNDROME 12 0.0015
543 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
544 MIGRAINE 138 0.0014
545 FATIGUE 1117 0.0014
546 BONE PAIN 84 0.0014
547 GASTROINTESTINAL DISORDER 128 0.0014
548 RASH PAPULAR 32 0.0014
549 HAEMORRHAGE 149 0.0014
550 MUSCULOSKELETAL CHEST PAIN 22 0.0014
551 WRIST FRACTURE 17 0.0014
552 TACHYPNOEA 19 0.0014
553 CARDIO-RESPIRATORY ARREST 58 0.0014
554 FLANK PAIN 13 0.0014
555 STRESS CARDIOMYOPATHY 8 0.0014
556 PHARYNGITIS 17 0.0014
557 BEDRIDDEN 18 0.0014
558 INCREASED UPPER AIRWAY SECRETION 7 0.0014
559 HEPATIC FAILURE 41 0.0014
560 APPETITE DISORDER 9 0.0014
561 HOT FLUSH 102 0.0014
562 FEELING ABNORMAL 322 0.0013
563 PULMONARY MASS 20 0.0013
564 GASTROINTESTINAL INFECTION 12 0.0013
565 EAR PAIN 26 0.0013
566 FEEDING DISORDER 27 0.0013
567 ULCER HAEMORRHAGE 9 0.0013
568 PAROSMIA 10 0.0013
569 COAGULOPATHY 22 0.0013
570 LOCAL SWELLING 23 0.0013
571 UNRESPONSIVE TO STIMULI 34 0.0013
572 INGUINAL HERNIA 8 0.0013
573 THROAT IRRITATION 59 0.0013
574 ATRIAL SEPTAL DEFECT 11 0.0013
575 HIP FRACTURE 42 0.0013
576 RESPIRATORY DISORDER 39 0.0013
577 INJECTION SITE DISCHARGE 7 0.0013
578 UNDERDOSE 95 0.0013
579 RASH 567 0.0013
580 AUTOIMMUNE HEPATITIS 9 0.0013
581 SNEEZING 29 0.0013
582 ANKLE FRACTURE 20 0.0013
583 WOUND 36 0.0013
584 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 22 0.0013
585 APPLICATION SITE REACTION 9 0.0013
586 OROPHARYNGEAL PAIN 117 0.0013
587 SKIN DISCOLOURATION 58 0.0013
588 NEUTROPENIC SEPSIS 9 0.0013
589 LACRIMATION INCREASED 38 0.0013
590 LIVER FUNCTION TEST INCREASED 27 0.0013
591 SLEEP APNOEA SYNDROME 24 0.0013
592 LETHARGY 72 0.0013
593 PULMONARY FIBROSIS 24 0.0012
594 HERNIA 24 0.0012
595 LIVER FUNCTION TEST ABNORMAL 36 0.0012
596 INCOHERENT 8 0.0012
597 CHOLECYSTITIS ACUTE 7 0.0012
598 HYPOKALAEMIA 57 0.0012
599 GASTROENTERITIS 18 0.0012
600 AUTOIMMUNE DISORDER 12 0.0012
601 MOUTH HAEMORRHAGE 9 0.0012
602 CARDIAC VALVE DISEASE 7 0.0012
603 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
604 PRODUCT PREPARATION ISSUE 8 0.0012
605 MULTI-ORGAN FAILURE 21 0.0012
606 ARTHROPOD BITE 9 0.0012
607 EMBOLISM 10 0.0012
608 WHITE BLOOD CELL COUNT INCREASED 46 0.0012
609 WHEEZING 71 0.0012
610 ASPARTATE AMINOTRANSFERASE INCREASED 63 0.0012
611 PANCREATITIS 62 0.0012
612 GASTROOESOPHAGEAL REFLUX DISEASE 94 0.0012
613 BLOOD SODIUM DECREASED 22 0.0012
614 PSEUDOMONAS INFECTION 10 0.0012
615 FOOT FRACTURE 22 0.0012
616 FALL 385 0.0012
617 FAECES DISCOLOURED 25 0.0012
618 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 60 0.0011
619 PREGNANCY 23 0.0011
620 SPINAL FRACTURE 23 0.0011
621 ARTHRALGIA 474 0.0011
622 SKIN REACTION 16 0.0011
623 HYPERCALCAEMIA 14 0.0011
624 TREATMENT NONCOMPLIANCE 62 0.0011
625 THROMBOSIS 91 0.0011
626 CYSTITIS 36 0.0011
627 CONSTIPATION 245 0.0011
628 MUSCLE TIGHTNESS 18 0.0011
629 ACUTE KIDNEY INJURY 170 0.0011
630 DRUG INTOLERANCE 107 0.0011
631 BLOOD CREATININE INCREASED 72 0.0011
632 GASTRITIS 29 0.0011
633 LIQUID PRODUCT PHYSICAL ISSUE 8 0.0011
634 ASPIRATION 12 0.0011
635 HYPERAESTHESIA 9 0.0011
636 DEVICE USE ERROR 38 0.0011
637 PRODUCT DOSE OMISSION 71 0.0011
638 UROSEPSIS 10 0.0011
639 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
640 ROAD TRAFFIC ACCIDENT 45 0.0011
641 PAIN 659 0.0011
642 ADRENAL INSUFFICIENCY 13 0.0011
643 URINARY TRACT INFECTION 182 0.0011
644 PHOTOPHOBIA 20 0.0011
645 STATUS EPILEPTICUS 12 0.0011
646 VENTRICULAR EXTRASYSTOLES 11 0.0011
647 FLATULENCE 60 0.0011
648 ADVERSE REACTION 14 0.0011
649 PETECHIAE 11 0.0011
650 RECALLED PRODUCT ADMINISTERED 10 0.0010
651 MELAENA 23 0.0010
652 HAEMATOMA 27 0.0010
653 CARDIAC MURMUR 9 0.0010
654 SUDDEN DEATH 11 0.0010
655 LIMB DISCOMFORT 32 0.0010
656 LOWER RESPIRATORY TRACT INFECTION 47 0.0010
657 ADVERSE EVENT 95 0.0010
658 BRAIN OEDEMA 13 0.0010
659 GENERAL PHYSICAL HEALTH DETERIORATION 119 0.0010
660 WOUND INFECTION 11 0.0010
661 UPPER LIMB FRACTURE 20 0.0010
662 HAEMORRHAGE INTRACRANIAL 15 0.0010
663 APHONIA 14 0.0010
664 EXTRASYSTOLES 7 0.0010
665 TOOTH FRACTURE 11 0.0010
666 NERVOUSNESS 52 0.0010
667 LEUKOCYTOSIS 18 0.0010
668 THERAPY CESSATION 51 0.0010
669 NIGHT SWEATS 32 0.0010
670 HYPERHIDROSIS 127 0.0010
671 DRY THROAT 10 0.0010
672 JOINT INJURY 21 0.0010
673 BRONCHOSPASM 14 0.0010
674 COLITIS 37 0.0010
675 EYE HAEMORRHAGE 13 0.0010
676 INFLUENZA LIKE ILLNESS 80 0.0010
677 EYE SWELLING 36 0.0010
678 SPINAL COMPRESSION FRACTURE 8 0.0010
679 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
680 ALANINE AMINOTRANSFERASE INCREASED 59 0.0010
681 SKIN DISORDER 32 0.0010
682 FOETAL EXPOSURE DURING PREGNANCY 77 0.0009
683 PERIPHERAL COLDNESS 13 0.0009
684 BLISTER 53 0.0009
685 ULCER 15 0.0009
686 MATERNAL EXPOSURE DURING PREGNANCY 84 0.0009
687 SCIATICA 15 0.0009
688 EATING DISORDER 20 0.0009
689 MUSCLE SPASMS 172 0.0009
690 RESTLESS LEGS SYNDROME 17 0.0009
691 PRODUCT CONTAINER ISSUE 8 0.0009
692 BODY TEMPERATURE INCREASED 19 0.0009
693 ANURIA 8 0.0009
694 HYPOACUSIS 40 0.0009
695 THROMBOTIC MICROANGIOPATHY 9 0.0009
696 HERPES ZOSTER 53 0.0009
697 SINUS TACHYCARDIA 13 0.0009
698 HIP ARTHROPLASTY 14 0.0009
699 BOWEL MOVEMENT IRREGULARITY 7 0.0009
700 LIGAMENT SPRAIN 9 0.0009
701 ANXIETY 259 0.0009
702 RED BLOOD CELL COUNT DECREASED 26 0.0009
703 VENTRICULAR TACHYCARDIA 15 0.0009
704 PARALYSIS 13 0.0009
705 ARRHYTHMIA 43 0.0009
706 RECTAL HAEMORRHAGE 39 0.0009
707 RESPIRATORY ARREST 25 0.0009
708 HAEMATOCHEZIA 50 0.0009
709 ENCEPHALOPATHY 22 0.0009
710 FACE OEDEMA 15 0.0009
711 BLOOD CALCIUM DECREASED 10 0.0009
712 EYE INFECTION 10 0.0009
713 DRUG ADMINISTRATION ERROR 27 0.0009
714 RIB FRACTURE 18 0.0009
715 DERMATITIS ALLERGIC 11 0.0009
716 TEMPERATURE INTOLERANCE 9 0.0009
717 HAEMORRHOIDS 17 0.0009
718 FUNGAL INFECTION 29 0.0009
719 JOINT SWELLING 105 0.0009
720 NERVE COMPRESSION 8 0.0009
721 DIVERTICULITIS 24 0.0009
722 POST PROCEDURAL INFECTION 7 0.0009
723 PULMONARY EMBOLISM 81 0.0009
724 CONTUSION 82 0.0009
725 NEUROPATHY PERIPHERAL 80 0.0008
726 TASTE DISORDER 17 0.0008
727 PRURITUS GENERALISED 18 0.0008
728 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
729 CANDIDA INFECTION 14 0.0008
730 HEART RATE DECREASED 29 0.0008
731 FACIAL PARALYSIS 7 0.0008
732 HYPONATRAEMIA 46 0.0008
733 FREQUENT BOWEL MOVEMENTS 22 0.0008
734 SKIN ULCER 21 0.0008
735 VENTRICULAR FIBRILLATION 9 0.0008
736 RENAL IMPAIRMENT 68 0.0008
737 DISORIENTATION 32 0.0008
738 CYST 10 0.0008
739 JOINT STIFFNESS 21 0.0008
740 BRAIN INJURY 8 0.0008
741 TOXIC SKIN ERUPTION 8 0.0008
742 EMPHYSEMA 8 0.0008
743 MUSCLE ATROPHY 10 0.0008
744 PHOTOSENSITIVITY REACTION 13 0.0008
745 FEELING JITTERY 15 0.0008
746 SUBARACHNOID HAEMORRHAGE 8 0.0008
747 HYPERSENSITIVITY 144 0.0008
748 HIATUS HERNIA 10 0.0008
749 PANIC ATTACK 28 0.0008
750 MUSCULAR WEAKNESS 87 0.0008
751 DEAFNESS 20 0.0008
752 INTERSTITIAL LUNG DISEASE 37 0.0008
753 BURNING SENSATION 53 0.0008
754 ABSCESS 12 0.0008
755 SURGERY 44 0.0007
756 HEPATIC FUNCTION ABNORMAL 28 0.0007
757 SKIN HAEMORRHAGE 11 0.0007
758 EOSINOPHILIA 13 0.0007
759 COLON CANCER 11 0.0007
760 INSOMNIA 196 0.0007
761 BACK INJURY 8 0.0007
762 DYSPHONIA 43 0.0007
763 PNEUMONITIS 20 0.0007
764 OESOPHAGITIS 8 0.0007
765 PRODUCT PREPARATION ERROR 15 0.0007
766 PERITONITIS 15 0.0007
767 PNEUMONIA ASPIRATION 18 0.0007
768 MASS 10 0.0007
769 HYPERKALAEMIA 25 0.0007
770 OCULAR DISCOMFORT 8 0.0007
771 BLINDNESS UNILATERAL 10 0.0007
772 LYMPHADENOPATHY 25 0.0007
773 GENITAL HAEMORRHAGE 9 0.0007
774 CEREBRAL HAEMORRHAGE 25 0.0007
775 NEPHROLITHIASIS 32 0.0007
776 DRUG DOSE OMISSION 115 0.0007
777 GAIT INABILITY 23 0.0007
778 HYPOAESTHESIA 103 0.0007
779 INCORRECT DOSE ADMINISTERED BY DEVICE 18 0.0007
780 BLOOD URINE PRESENT 13 0.0007
781 RENAL FAILURE ACUTE 29 0.0007
782 DEPRESSED MOOD 36 0.0007
783 CONFUSIONAL STATE 109 0.0007
784 EYE PAIN 38 0.0007
785 ERUCTATION 13 0.0007
786 THIRST 12 0.0007
787 DERMATITIS 14 0.0007
788 HYPOPHAGIA 17 0.0007
789 HYPERSOMNIA 19 0.0007
790 OSTEOMYELITIS 12 0.0007
791 ILLNESS 68 0.0007
792 GINGIVAL BLEEDING 9 0.0007
793 BLOOD UREA INCREASED 11 0.0007
794 PRURITUS 250 0.0006
795 POOR QUALITY SLEEP 14 0.0006
796 POLLAKIURIA 27 0.0006
797 PARAESTHESIA 101 0.0006
798 URINARY INCONTINENCE 19 0.0006
799 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 35 0.0006
800 GASTROINTESTINAL PAIN 7 0.0006
801 ABDOMINAL PAIN LOWER 16 0.0006
802 URTICARIA 106 0.0006
803 TREMOR 105 0.0006
804 GASTRIC ULCER 12 0.0006
805 PAIN OF SKIN 17 0.0006
806 VISION BLURRED 86 0.0006
807 DEVICE DEPLOYMENT ISSUE 8 0.0006
808 IMPAIRED QUALITY OF LIFE 9 0.0006
809 PANCREATITIS ACUTE 14 0.0006
810 DRUG ERUPTION 11 0.0006
811 ARTHRITIS 48 0.0006
812 LUNG NEOPLASM MALIGNANT 25 0.0006
813 IRRITABLE BOWEL SYNDROME 13 0.0006
814 EYELID OEDEMA 7 0.0006
815 HYPOTHYROIDISM 19 0.0006
816 METABOLIC ACIDOSIS 19 0.0006
817 HEMIPARESIS 10 0.0006
818 OCULAR HYPERAEMIA 28 0.0006
819 TINNITUS 27 0.0006
820 BRADYCARDIA 31 0.0006
821 HEPATOTOXICITY 13 0.0006
822 CORONARY ARTERY OCCLUSION 8 0.0006
823 SKIN LESION 16 0.0006
824 C-REACTIVE PROTEIN INCREASED 21 0.0006
825 THERAPY PARTIAL RESPONDER 9 0.0006
826 LIP SWELLING 19 0.0006
827 BLOOD TEST ABNORMAL 8 0.0006
828 CHOKING 11 0.0006
829 DEVICE DELIVERY SYSTEM ISSUE 15 0.0005
830 BLOOD GLUCOSE ABNORMAL 10 0.0005
831 INJECTION SITE INDURATION 7 0.0005
832 MEMORY IMPAIRMENT 74 0.0005
833 DYSGEUSIA 40 0.0005
834 GAIT DISTURBANCE 103 0.0005
835 CATARACT 32 0.0005
836 SEIZURE 62 0.0005
837 HYPOCALCAEMIA 10 0.0005
838 INTENTIONAL DOSE OMISSION 15 0.0005
839 ANGINA PECTORIS 15 0.0005
840 INCREASED APPETITE 10 0.0005
841 MALIGNANT MELANOMA 7 0.0005
842 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25 0.0005
843 PHARYNGEAL OEDEMA 8 0.0005
844 ACCIDENTAL OVERDOSE 19 0.0005
845 DYSURIA 19 0.0005
846 NEUROTOXICITY 9 0.0005
847 BRAIN FOG 8 0.0005
848 ILL-DEFINED DISORDER 31 0.0005
849 VAGINAL HAEMORRHAGE 22 0.0005
850 DISSEMINATED INTRAVASCULAR COAGULATION 7 0.0005
851 SOMNOLENCE 100 0.0005
852 CONJUNCTIVITIS 9 0.0005
853 AGEUSIA 12 0.0005
854 BLOOD GLUCOSE DECREASED 23 0.0005
855 ACUTE MYOCARDIAL INFARCTION 14 0.0005
856 DRY MOUTH 38 0.0005
857 NEOPLASM MALIGNANT 31 0.0005
858 HYPOAESTHESIA ORAL 7 0.0005
859 ORTHOSTATIC HYPOTENSION 8 0.0005
860 VERTIGO 28 0.0005
861 PRODUCT USE ISSUE 86 0.0005
862 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
863 FIBROMYALGIA 11 0.0005
864 LIVER INJURY 11 0.0004
865 ORAL PAIN 10 0.0004
866 ABASIA 11 0.0004
867 THROAT TIGHTNESS 12 0.0004
868 CHROMATURIA 10 0.0004
869 LABORATORY TEST ABNORMAL 13 0.0004
870 BACK DISORDER 7 0.0004
871 APHASIA 13 0.0004
872 HYPERTENSION 90 0.0004
873 ADVERSE DRUG REACTION 38 0.0004
874 LEUKOPENIA 21 0.0004
875 PERICARDITIS 7 0.0004
876 BALANCE DISORDER 36 0.0004
877 HEPATIC CANCER 10 0.0004
878 CRYING 15 0.0004
879 PANCYTOPENIA 23 0.0004
880 SLEEP DISORDER 29 0.0004
881 COVID-19 72 0.0004
882 DISCOMFORT 25 0.0004
883 INFLAMMATION 21 0.0004
884 ANGIOEDEMA 18 0.0004
885 TRANSAMINASES INCREASED 9 0.0004
886 TOOTH DISORDER 9 0.0004
887 CEREBROVASCULAR ACCIDENT 68 0.0004
888 DEVICE USE ISSUE 7 0.0004
889 DYSARTHRIA 15 0.0004
890 VISUAL IMPAIRMENT 49 0.0004
891 EYE DISORDER 13 0.0004
892 SKIN EXFOLIATION 33 0.0004
893 AMNESIA 25 0.0004
894 BLOOD PRESSURE FLUCTUATION 9 0.0004
895 DRY SKIN 50 0.0004
896 INTESTINAL OBSTRUCTION 14 0.0004
897 OFF LABEL USE 324 0.0004
898 IMPAIRED HEALING 12 0.0004
899 GLOSSODYNIA 8 0.0004
900 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
901 DISABILITY 7 0.0004
902 DEEP VEIN THROMBOSIS 23 0.0004
903 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
904 HYPOGLYCAEMIA 17 0.0004
905 HAEMATURIA 12 0.0004
906 DYSPHAGIA 33 0.0003
907 THERAPEUTIC RESPONSE DECREASED 21 0.0003
908 DELIRIUM 12 0.0003
909 ECZEMA 18 0.0003
910 DYSSTASIA 10 0.0003
911 HEPATIC ENZYME INCREASED 23 0.0003
912 COLITIS ULCERATIVE 15 0.0003
913 JAUNDICE 9 0.0003
914 KNEE ARTHROPLASTY 7 0.0003
915 MOOD ALTERED 9 0.0003
916 CHRONIC KIDNEY DISEASE 25 0.0003
917 ASTHMA 37 0.0003
918 BLOOD PRESSURE INCREASED 50 0.0003
919 MUSCULOSKELETAL STIFFNESS 28 0.0003
920 PRODUCT DOSE OMISSION ISSUE 92 0.0003
921 EYE IRRITATION 18 0.0003
922 DEPRESSION 70 0.0003
923 SPEECH DISORDER 16 0.0003
924 MYOCARDIAL INFARCTION 53 0.0003
925 HYPERGLYCAEMIA 11 0.0003
926 RESTLESSNESS 11 0.0003
927 MENTAL DISORDER 13 0.0003
928 BLINDNESS 12 0.0003
929 FEMUR FRACTURE 9 0.0003
930 DRUG INEFFECTIVE 381 0.0003
931 CEREBRAL INFARCTION 7 0.0003
932 AGITATION 21 0.0003
933 LACTIC ACIDOSIS 9 0.0003
934 INJECTION SITE ERYTHEMA 34 0.0003
935 HEPATITIS 7 0.0003
936 INJECTION SITE PRURITUS 18 0.0003
937 BREAST CANCER 25 0.0003
938 OSTEOPOROSIS 11 0.0003
939 DIABETES MELLITUS 20 0.0003
940 PRODUCT USE IN UNAPPROVED INDICATION 65 0.0003
941 FEAR 7 0.0003
942 DRUG DOSE OMISSION BY DEVICE 20 0.0003
943 COMA 12 0.0003
944 MEDICATION ERROR 14 0.0003
945 THERAPY INTERRUPTED 18 0.0003
946 ACNE 19 0.0003
947 DEMENTIA 7 0.0003
948 DISTURBANCE IN ATTENTION 13 0.0002
949 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
950 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
951 IRRITABILITY 14 0.0002
952 INJECTION SITE RASH 7 0.0002
953 EMOTIONAL DISORDER 7 0.0002
954 ALOPECIA 44 0.0002
955 MOVEMENT DISORDER 7 0.0002
956 TREATMENT FAILURE 18 0.0002
957 SKIN BURNING SENSATION 15 0.0002
958 PLASMA CELL MYELOMA 8 0.0002
959 INCORRECT DOSE ADMINISTERED 46 0.0002
960 DRY EYE 10 0.0002
961 PRODUCT QUALITY ISSUE 27 0.0002
962 ARTHROPATHY 11 0.0002
963 OVERDOSE 42 0.0002
964 CONVULSION 11 0.0002
965 OSTEOARTHRITIS 8 0.0002
966 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
967 DEVICE DIFFICULT TO USE 11 0.0002
968 HALLUCINATION 12 0.0002
969 MOBILITY DECREASED 11 0.0002
970 NO ADVERSE EVENT 27 0.0001
971 STOMATITIS 9 0.0001
972 DISEASE RECURRENCE 7 0.0001
973 ANAPHYLACTIC REACTION 8 0.0001
974 RHEUMATOID ARTHRITIS 16 0.0001
975 DRUG INTERACTION 22 0.0001
976 INTENTIONAL PRODUCT MISUSE 12 0.0001
977 NEUTROPENIA 18 0.0001
978 FEBRILE NEUTROPENIA 8 0.0001
979 SUICIDAL IDEATION 11 0.0001
980 DRUG WITHDRAWAL SYNDROME 10 0.0001
981 INJECTION SITE HAEMORRHAGE 9 0.0001
982 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
983 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
984 INJECTION SITE SWELLING 8 0.0001
985 INJECTION SITE PAIN 31 0.0001
986 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
987 BLOOD GLUCOSE INCREASED 18 0.0001
988 PRODUCT STORAGE ERROR 8 0.0001
989 TOXICITY TO VARIOUS AGENTS 15 0.0001
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16 0.0001
991 EMOTIONAL DISTRESS 7 0.0001